Clinical decision support for ICU antimicrobial therapy. Evidence-based 8-phase workflow with integrated safety systems, renal dosing, culture de-escalation, and treatment failure analysis.
From patient entry to treatment optimization, every step is guided by evidence-based protocols and safety checks.
Patient demographics, renal function (CrCl), allergies, pregnancy status, and CRRT documentation.
CAP, HAP, VAP, cIAI, cSSTI, meningitis, febrile neutropenia, and more infection syndromes.
Select target pathogens for empiric coverage based on syndrome and risk factors.
Evidence-based antimicrobial combinations with allergy checking and safety validation.
Weight-based, renal-adjusted, and CRRT-specific dosing calculations.
5-state culture machine with mandatory de-escalation prompts and justification.
Treatment failure classification, corrective strategies, and escalation pathways.
Case documentation, timeline audit trail, and print-ready reports.
Every feature designed with ICU workflow and patient safety in mind.
Multi-layer protection against allergic reactions with cross-reactivity detection.
Automated dose calculations based on patient parameters and renal function.
Structured 5-state culture workflow with mandatory de-escalation prompts.
Responsive design that works seamlessly on phones, tablets, and desktops.
Install as a PWA and use without internet connection. Perfect for ICU environments.
Generate medico-legal grade documentation with complete audit trails.
Start with a free trial. Upgrade when you're ready.
AIE™ was developed from years of ICU experience, addressing the real challenges of antimicrobial stewardship in resource-limited settings. Every feature is designed to support clinical decision-making while maintaining patient safety at the forefront.
Contact Dr. Amir Fadhel directly for licensing and institutional plans.
💳 PayPal accepted • Individual & Institutional licenses available
Response within 24 hours • All inquiries confidential